Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1974 3
1984 1
1985 1
1987 1
1988 1
1989 1
1990 3
1991 1
1992 3
1993 2
1995 3
1996 3
1997 3
1998 1
1999 3
2000 4
2001 3
2002 3
2003 4
2004 6
2005 1
2006 7
2008 5
2009 5
2010 7
2011 13
2012 6
2013 5
2014 6
2015 6
2016 7
2017 4
2018 1
2019 2
2020 3
2021 7
2022 3
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

131 results
Results by year
Filters applied: . Clear all
Page 1
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial.
de Groot P, Nikolic T, Pellegrini S, Sordi V, Imangaliyev S, Rampanelli E, Hanssen N, Attaye I, Bakker G, Duinkerken G, Joosten A, Prodan A, Levin E, Levels H, Potter van Loon B, van Bon A, Brouwer C, van Dam S, Simsek S, van Raalte D, Stam F, Gerdes V, Hoogma R, Diekman M, Gerding M, Rustemeijer C, de Bakker B, Hoekstra J, Zwinderman A, Bergman J, Holleman F, Piemonti L, De Vos W, Roep B, Nieuwdorp M. de Groot P, et al. Among authors: van bon a. Gut. 2021 Jan;70(1):92-105. doi: 10.1136/gutjnl-2020-322630. Epub 2020 Oct 26. Gut. 2021. PMID: 33106354 Free PMC article. Clinical Trial.
Type I interferon as a stimulus for cross-priming.
Le Bon A, Tough DF. Le Bon A, et al. Cytokine Growth Factor Rev. 2008 Feb;19(1):33-40. doi: 10.1016/j.cytogfr.2007.10.007. Cytokine Growth Factor Rev. 2008. PMID: 18068417 Review.
The PRolaCT studies - a study protocol for a combined randomised clinical trial and observational cohort study design in prolactinoma.
Zandbergen IM, Zamanipoor Najafabadi AH, Pelsma ICM, van den Akker-van Marle ME, Bisschop PHLT, Boogaarts HDJ, van Bon AC, Burhani B, le Cessie S, Dekkers OM, Drent ML, Feelders RA, de Graaf JP, Hoogmoed J, Kapiteijn KK, van der Klauw MM, Nieuwlaat WCM, Pereira AM, Stades AME, van de Ven AC, Wakelkamp IMMJ, van Furth WR, Biermasz NR; Dutch Prolactinoma Study Group. Zandbergen IM, et al. Among authors: van bon ac. Trials. 2021 Sep 25;22(1):653. doi: 10.1186/s13063-021-05604-y. Trials. 2021. PMID: 34563236 Free PMC article.
Direct effects of type I interferons on cells of the immune system.
Hervas-Stubbs S, Perez-Gracia JL, Rouzaut A, Sanmamed MF, Le Bon A, Melero I. Hervas-Stubbs S, et al. Among authors: le bon a. Clin Cancer Res. 2011 May 1;17(9):2619-27. doi: 10.1158/1078-0432.CCR-10-1114. Epub 2011 Mar 3. Clin Cancer Res. 2011. PMID: 21372217 Free article. Review.
[A woman with oedema of the lower legs].
Wolthuis DFGJ, van Bon AC. Wolthuis DFGJ, et al. Among authors: van bon ac. Ned Tijdschr Geneeskd. 2021 Jun 10;165:D5913. Ned Tijdschr Geneeskd. 2021. PMID: 34346645 Dutch.
131 results